Tumor on a chip (IMAGE)
Caption
Penn engineers and collaborators have developed a transparent, micro-engineered device that houses a living, vascularized model of human lung cancer—a “tumor on a chip”—and show that the diabetes drug vildagliptin helps more CAR T cells break through the tumor’s defenses and attack it effectively.
Credit
Dan Dongeun Huh
Usage Restrictions
Seek permission to redistribute.
License
Original content